Flibanserin: A controversial drug for female hypoactive sexual desire disorder

Sexual functioning is an integral part of human life. Female sexual dysfunction (FSD) adversely affects quality of life and general well-being. The Food and Drug Administration recently approved flibanserin, for treatment of female hypoactive sexual desire disorder (HSDD), regarded as the most commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Baid, Rashmi, Agarwal, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198608/
https://www.ncbi.nlm.nih.gov/pubmed/30416308
http://dx.doi.org/10.4103/ipj.ipj_20_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198608/
https://www.ncbi.nlm.nih.gov/pubmed/30416308
http://dx.doi.org/10.4103/ipj.ipj_20_16

Ejemplares similares